Nutrisukan Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.11 M
as on 30-10-2024
- Paid Up Capital ₹ 0.10 M
as on 30-10-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 997.28%
(FY 2023)
- Profit -122.61%
(FY 2023)
- Ebitda -124.78%
(FY 2023)
- Net Worth -37.98%
(FY 2023)
- Total Assets 88.51%
(FY 2023)
About Nutrisukan Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.11 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raghavendra Shetty, Manjunatha Paramashivaiah, Barkur Roshini, and One other member serve as directors at the Company.
- CIN/LLPIN
U24297KA2021PTC152797
- Company No.
152797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nutrisukan Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghavendra Shetty  | Managing Director | 07-Oct-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjunatha Paramashivaiah | Director | 07-Oct-2021 | Current |
| Barkur Roshini | Director | 07-Oct-2021 | Current |
| Sukanya Paramashivaiah | Director | 07-Oct-2021 | Current |
Financial Performance of Nutrisukan Biotech.
Nutrisukan Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 997.28% increase. The company also saw a substantial fall in profitability, with a 122.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutrisukan Biotech?
Unlock access to Nutrisukan Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Reach4cause Technologies Private LimitedActive 6 years 9 monthsRaghavendra Shetty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutrisukan Biotech?
Nutrisukan Biotech has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutrisukan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutrisukan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
